Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial
Juan Carlos Tinoco, Noris Pavia-Ruz, Aurelio Cruz-Valdez, Carlos Aranza Doniz, Vijayalakshmi Chandrasekaran, Walthère Dewé, Aixue Liu, Bruce L Innis, Varsha K Jain, Juan Carlos Tinoco, Noris Pavia-Ruz, Aurelio Cruz-Valdez, Carlos Aranza Doniz, Vijayalakshmi Chandrasekaran, Walthère Dewé, Aixue Liu, Bruce L Innis, Varsha K Jain
Abstract
Background: Two influenza B lineages have been co-circulating since the 1980s, and because inactivated trivalent influenza vaccine (TIV) contains only one B strain, it provides little/no protection against the alternate B-lineage. We assessed a candidate inactivated quadrivalent influenza vaccine (QIV) containing both B lineages versus TIV in healthy adults.
Methods: Subjects received one dose of QIV (lot 1, 2, or 3) or one of two TIVs (B strain from Victoria or Yamagata lineage); randomization was 2:2:2:1:1. Hemagglutination-inhibition assays were performed 21-days post-vaccination; superiority of QIV versus TIV for the alternate B-lineage was demonstrated if the 95% confidence interval (CI) lower limit for the GMT ratio was ≥1.5, and non-inferiority against the shared strains was demonstrated if the 95% CI upper limit for the GMT ratio was ≤1.5. Reactogenicity and safety were assessed during the post-vaccination period. NCT01196975.
Results: Immunogenicity of QIV lots was consistent, QIV was superior to TIV for the alternate B-lineage strain, and QIV was non-inferior versus TIVs for shared strains (A/H1N1, A/H3N2, B-strain). Reactogenicity and safety profile of the QIV was consistent with seasonal influenza vaccines.
Conclusion: QIV provided superior immunogenicity for the added B strain without affecting the antibody response to the TIV strains, and without compromising safety.
Keywords: Inactivated quadrivalent influenza vaccine; Seasonal influenza; Victoria lineage; Yamagata lineage.
Copyright © 2014. Published by Elsevier Ltd.
Source: PubMed